Rapid Effect of Lansoprazole on Intragastric pH: a Crossover Comparison with Omeprazole
- 1 January 1999
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 34 (4) , 341-345
- https://doi.org/10.1080/003655299750026335
Abstract
The time to onset of acid inhibition is considered an important factor when treating patients with reflux symptoms. This study was therefore designed to investigate the effect of 30 mg lansoprazole and 20 mg omeprazole on gastric pH after single-dose administration. The study was of a randomized, open-label, single-dose and two-way crossover design with a washout period of at least 7 days in between. Fifteen healthy adult male and female subjects were included. The subjects were intubated with a pH catheter. Intragastric pH was measured every 4th sec for 10 min before and during 8 h after drug administration. Blood samples, for determination of plasma concentrations of lansoprazole and omeprazole, were obtained on 10 occasions during 6 h after drug administration. The area under the curve (AUC), the elimination halflife (t1/2), and the peak concentration (Cmax) of the two drugs were calculated. All subjects completed the study without major complications. The mean pH (0-8 h) after drug administration was 2.9 for lansoprazole and 2.0 for omeprazole (P = 0.0058). A pH of more than 4 was reached for the first time after 130 min with lansoprazole and after 250 min with omeprazole. AUC was 4919 +/- 2526 nmol/l x h for lansoprazole and 1352 +/- 1120 nmol/l x h for omeprazole. Single-dose administration of 30 mg lansoprazole is followed by a rapid absorption of the drug and hence a more efficient acid suppression than after single-dose administration of 20 mg omeprazole in healthy volunteers.Keywords
This publication has 13 references indexed in Scilit:
- Pantoprazole: a new and more specific proton pump inhibitorExpert Opinion on Investigational Drugs, 1997
- The Effects of Oral Doses of Lansoprazole and Omeprazole on Gastric pHJournal of Clinical Gastroenterology, 1997
- Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mgEuropean Journal of Gastroenterology & Hepatology, 1997
- Pharmacokinetic Optimisation in the Treatment of Gastro-Oesophageal Reflux DiseaseClinical Pharmacokinetics, 1996
- Pharmacokinetics and absolute bioavailability of lansoprazoleEuropean Journal of Clinical Pharmacology, 1996
- Lansoprazole versus Omeprazole in Active Duodenal Ulcer a Double-Blind, Randomized, Comparative StudyScandinavian Journal of Gastroenterology, 1995
- The effects of lansoprazole, a new H+,K+‐ATPase inhibitor, on gastric pH and serum gastrinAlimentary Pharmacology & Therapeutics, 1992
- Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.Gut, 1992
- The Pharmacokinetics of Single and Repeated Once-Daily Doses of 10, 20 and 40mg Omeprazole as Enteric-Coated GranulesClinical Drug Investigation, 1991
- Heartburn--the acid test.Gut, 1989